1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with b 3824 in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (b 3824) | Trials (b 3824) | Recent Studies (post-2010) (b 3824) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 6 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hellewell, PG; Jose, PJ; Williams, TJ | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and b 3824
Article | Year |
---|---|
Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.
Topics: Animals; Aprotinin; Blood Coagulation Factors; Bradykinin; Complement C5a; Dinoprostone; Edema; Fluoroacetates; Histamine Antagonists; Immunoglobulin E; Indomethacin; Lipoxygenase Inhibitors; Male; Neutrophils; Oligopeptides; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Quinolines; Rabbits; Specific Pathogen-Free Organisms | 1992 |